Bugan, Ilknur
Kucuk, Selma
Karagoz, Zeynep
Fraser, Scott P.
Kaya, Handan
Dodson, Andrew
Foster, Christopher S.
Altun, Seyhan
Djamgoz, Mustafa B. A.
Article History
Received: 24 July 2018
Revised: 3 December 2018
Accepted: 26 December 2018
First Online: 20 March 2019
Compliance with ethical standards
:
: MBAD is involved in a spinout company developing voltage-gated sodium channel blockers as anti-metastatic drugs. However, the current work received no financial support from this company that could have influenced its outcome.